From adtech to healthtech, Jonathon Wolf has built ZOE into one of the world’s leading nutrition science companies, translating cutting-edge microbiome research into tools that help millions improve their health. We sat down with Jonathon to explore how ZOE turns complex science into daily action, what it takes to build trust at the intersection of research and consumers, and why personalised nutrition could redefine preventative healthcare.

From Airbus executive to space entrepreneur, Hélène Huby is leading Europe’s bid to build its own SpaceX with The Exploration Company. We sat down with Hélène to talk about reusable spacecraft, Europe’s growing space ambitions, and how international cooperation could define the next era of exploration.

From state-school beginnings in Sheffield to building one of Europe’s leading consumer AI companies, Cleo’s Barney Hussey-Yeo has spent the last decade redefining how people interact with money. We sat down with Barney to discuss his journey from data scientist to founder, the evolution of AI assistants, and what it takes to build a profitable, mission-driven fintech with personality.

The raw potential of generative AI has been made clear in recent years, but how can enterprises draw on the technology's full potential? And do so in a secure and compliant manner? Suranga Chandratillake sat down with Writer CEO and co-founder May Habib to discuss how the company's full-stack platform is making it faster and easier for organisations to build and deploy highly-customised AI apps. Find out more about Writer here and follow them on LinkedIn Find Balderton Capital here and...

From 10 Downing Street to deeptech investing, IQ Capital's Jonno Evans brings unique insight into the relationship between government and startups. We sat down with Jonno to explore the opportunity government has when faced with new technologies, how to encourage collaboration, and how to understand and bridge the culture around risk-taking. Find out more about IQ Capital and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

There's clear untapped potential as the world looks to decarbonize the energy sector: nuclear power. Blue Energy's CEO and co-founder Jake Jurewicz joins James Wise to discuss how offshore nuclear power plants can play a key role in building a sustainable and resilient energy grid of tomorrow. Find out more about Blue Energy here Find Balderton Capital here and follow us on LinkedIn

The UK is facing an acute shortage of bricklayers. At the same time, the new UK government has pledged to build 1.5m new homes over the next five years. Can bricklaying robots be the solution? Salar al Khafaji, CEO and co-founder of Dutch robotics startup Monumental, sat down with Suranga Chandratillake to why autonomous construction robots are the future, why Monumental was on construction sites as early as possible and lessons from Salar's first start-up. Find out more about Monumental her...

Drawing on her experience leading big social media platforms in their early days, we talk with Baroness Joanna Shields about what AI leaders need to get right when thinking about building their businesses, and how we’d accelerate the adoption of these new technologies in a safe and responsible way. Find out more about Precognition here and follow Baroness Joanna Shields on LinkedIn Find Balderton Capital here and follow us on LinkedIn

Painless real-time health monitoring at an affordable price? Listen to our chat with SAVA’s Renato Circi to find out how their advanced biosensing technology will deliver on this. Find out more about SAVA here and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

Coffee delivered to your doorstep via a drone? Manna Drone Delivery is already making it happen in the suburbs of Dublin and Texas. Tune into our conversation with founder and CEO Bobby Healy to learn more about how Manna are making deliveries more accessible in suburbs, the regulatory journey, and whether there’s a case for drones in space. Find out more about Manna Drone Delivery here and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery. Find out more about Labgenius here and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

Uncommon is using ground-breaking RNA cell technology to tackle the most pressing challenges to our health, starting with cultivated pork. Co-founder and CEO Benjamina Bollag sat down with James Wise to break down how cultivated meat will help tackle not only climate challenges, but also help improve global public health. Find out more about Uncommon here and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

Welcome to What's Next with Balderton Capital, where we take a closer look at emerging technologies, the people behind them and the potential impact on our lives. Wayve has just raised a landmark $1.05 billion Series C round to launch their first Embodied AI solutions for autonomous vehicles. James Wise sat down with co-founder and CEO Alex Kendall to chat about the company's early days, what embodied AI actually is, and why Wayve decided to tackle transportation first. Find out more abou...